Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,411 across all filing types
Latest filing 2021-02-03 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
SEC SCHEDULE 13G
Major Shareholding Notification
2021-02-03 English
TOTAL VOTING RIGHTS
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed by AstraZeneca PLC, which is a report of a foreign issuer submitted pursuant to the Securities Exchange Act of 1934. The content focuses on the total voting rights as of a specific date (31 January 2021) and provides details about the issued share capital and voting rights. It references the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, indicating it is a regulatory disclosure about voting rights rather than a full financial report or earnings release. The document length is 3196 characters, which is relatively short and primarily serves as a notification of voting rights rather than a detailed report. This fits the definition of a Major Shareholding Notification (MRQ) or a Declaration of Voting Results & Voting Rights Announcements (DVA). Since the document specifically states total voting rights and is intended for shareholders to determine notification requirements, it aligns best with Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-02-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the total number of voting rights and issued share capital as of a specific date (31 January 2021), which is a mandatory disclosure under the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory, periodic regulatory update that doesn't fit a more specific category (like Director's Dealing or Major Shareholding Notification) is best classified as a general Regulatory Filing or announcement. Given the options, 'Regulatory Filings (RNS)' is the most appropriate general category for an RNS announcement, although it specifically relates to voting rights/capital structure. Since there is no specific code for 'Voting Rights Notification', RNS serves as the best fit for a standard LSE regulatory news service release.
2021-02-01 English
ASTRAZENECA AGREES TO DIVEST VIELA SHAREHOLDING
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filing by AstraZeneca PLC, which is a report of a foreign issuer pursuant to the Securities Exchange Act of 1934. It announces AstraZeneca's agreement to divest its 26.7% ownership in Viela Bio, Inc. as part of Viela's acquisition by Horizon Therapeutics. The document provides details about the transaction, expected proceeds, and timing but does not contain comprehensive financial statements or detailed financial performance data. The length of the document is 3639 characters, which is relatively short and primarily serves as an announcement of a capital transaction rather than a full financial report. Therefore, this document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as divestments.
2021-02-01 English
AstraZeneca agrees to divest Viela shareholding
M&A Activity Classification · 99% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the concluding boilerplate text referencing the London Stock Exchange and the Financial Conduct Authority. The content details a specific corporate action: AstraZeneca agreeing to divest its shareholding in Viela Bio, Inc. This is a material event announcement that does not fit the specific definitions for Earnings Release (ER), Annual Report (10-K), Interim Report (IR), or a specific transaction like Director's Dealing (DIRS) or Share Issue (SHA). Since it is a general, material regulatory announcement provided through the official news service (RNS), and it is not a report itself (it's short and announces an action), the most appropriate classification is the general Regulatory Filings category, RNS, which serves as a catch-all for such official disclosures.
2021-02-01 English
COVID-19 VACCINE AUTHORISED FOR USE BY THE EU
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by AstraZeneca PLC, which is a report of a foreign issuer pursuant to the Securities Exchange Act of 1934. It provides an update on the authorization of the COVID-19 vaccine by the EU, including detailed information about the vaccine, clinical trials, and regulatory status. The document does not contain financial statements or detailed financial performance data, nor is it an annual or quarterly report. It is an informational update about a significant regulatory event related to the company's product. Form 6-K filings are typically considered Regulatory Filings (RNS) as they provide miscellaneous updates from foreign issuers that do not fit into other specific categories like Annual Reports or Earnings Releases. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-02-01 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.